TearScience

Headquartered in Morrisville, North Carolina, TearScience has pioneered devices that provide significant clinical identification and treatment of evaporative dry eye. Of the 100 million plus of dry eye sufferers worldwide, the leading cause (86percent) is evaporative dry eye, which is caused by Meibomian Gland Dysfunction (MGD) and a lipid deficiency of the eye’s natural tear film. The Tear Film and Ocular Surface Society (TFOS) workshop, involving two years of work by 50 leading experts from around the world, concluded that MGD is an under-estimated condition and is very likely the most frequent cause of dry eye disease. Common symptoms of the disease include eye irritation, dryness, redness, tiredness, and visual disturbances. TearScience’s integrated, in-office system enables eye care professionals to effectively address a root cause of evaporative dry eye.
Company Growth (employees)
Type
Private
HQ
Morrisville, US
Founded
2005
Size (employees)
97 (est)+8%
TearScience was founded in 2005 and is headquartered in Morrisville, US

Key People at TearScience

Steve Grenon

Steve Grenon

VP, Research & Development
Diethart Reichardt

Diethart Reichardt

SVP - European Region
Doug Pinotti

Doug Pinotti

GM, Asia Pacific & Latin America
Donald Korb

Donald Korb

CTO & Co - Founder
Wade Hampton

Wade Hampton

Chief Commercial Officer

TearScience Office Locations

TearScience has an office in Morrisville
Morrisville, US (HQ)
250 5151 McCrimmon Pkwy

TearScience Metrics

Summary Metrics

Founding Date

2005

Total Funding

$133.7 m

Latest funding size

$19.2 m

Time since last funding

about 1 year

Investors

TearScience's latest funding round in April 2016 was reported to be $19.2 m. In total, TearScience has raised $133.7 m

TearScience Online Presence

TearScience Company Life

You may also be interested in